The Relationship of the Medial Longitudinal Arch Height With Clinical Features of Knee Osteoarthritis
CompletedNCT05656014
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The goal of this observational study is to investigate the relationships between the medial longitudinal arch (MLA) height of the foot and clinical and radiological characteristics of knee osteoarthritis in adult patients 50 aged and over. The main questions it aims to answer are: * Is there any relationship between knee pain and disability in knee osteoarthritis and MLA height? * Is there any relationship between the radiologic severity of knee osteoarthritis and MLA height? * Is there any relationship between knee joint alignment in knee osteoarthritis and MLA height?
Study details
- Official title
- The Relationship of Medial Longitudinal Arch Height With Pain, Disease Severity and Knee Joint Alignment in Patients With Knee Osteoarthritis
- Conditions
- Foot Deformities
- Pes Planus
- Pes Cavus
- Knee Osteoarthritis
- Knee Pain Chronic
- Disability Physical
- Lower Limb Deformity
- Sponsor
- Gazi University
- Start date
- 2022-12-07
- Primary completion
- 2024-06-03
- Sex
- All
- Age range
- from 50 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Being 50 years old or older * Having a diagnosis of knee osteoarthritis according to the American College of Rheumatology Exclusion Criteria: * History of fracture or orthopaedic surgery involving lower limbs * Presence of neurological condition resulting in lower limb sensorimotor deficit * Having another inflammatory rheumatological disease * Having a malignant tumour with bone metastasis * Having lower limb oedema, lymphedema, skin and soft tissue loss that will prevent the evaluation of foot morphology (arch height index) * Severe neuropsychiatric disease or condition that interferes with communication * Having therapeutic injection into the knee joint in the last 3 months * Presence of any major trauma that aggravated knee pain in the last 6 weeks
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05656014